Isoform-specific interactions of human apolipoprotein E to an intermediate conformation of human Alzheimer amyloid-beta peptide

Chemistry and Physics of Lipids

Volumn 137, Issue 1-2, 2005, Pages 52-61

  Stratman, Nancy C ^a   Castle, Christine K ^a   Taylor, Bruce M ^a   Epps, Dennis E ^a   Melchior, George W ^a   Carter, Donald B ^a  

^a PFIZER INC   (United States)

Author keywords

Aggregation; Alzheimer's disease; Amyloid beta peptide; Apolipoprotein E; Deposition; Plaque

Indexed keywords

AMYLOID BETA PROTEIN; APOLIPOPROTEIN E;

ALZHEIMER DISEASE; AMINO TERMINAL SEQUENCE; ANTIBODY SPECIFICITY; ARTICLE; CARBOXY TERMINAL SEQUENCE; ENZYME LINKED IMMUNOSORBENT ASSAY; GENOTYPE PHENOTYPE CORRELATION; MOLECULAR RECOGNITION; NEUROPATHOLOGY; PRIORITY JOURNAL; PROTEIN AGGREGATION; PROTEIN BINDING; PROTEIN PROTEIN INTERACTION; PROTEIN VARIANT;

AMYLOID BETA-PROTEIN; APOLIPOPROTEIN E2; APOLIPOPROTEIN E3; APOLIPOPROTEIN E4; APOLIPOPROTEINS E; ENZYME-LINKED IMMUNOSORBENT ASSAY; HUMANS; PEPTIDE FRAGMENTS; PROTEIN BINDING; PROTEIN ISOFORMS; PROTEIN STRUCTURE, TERTIARY;

EID: 26044471824     PISSN: 00093084     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.chemphyslip.2005.06.005     Document Type: Article

References (39)

1. J.K. Boyles, C.D. Zoellner, L.J. Anderson, L.M. Kosik, R.E. Pitas, K.H. Weisgraber, D.Y. Hui, R.W. Mahley, P.J. Gebicke-Haerter, M.J. Ignatius, and E.M. Shooter Role for apolipoprotein E, apolipoprotein A-I, and low density lipoprotein receptors in cholesterol transport during regeneration and remyelination of the rat sciatic nerve J. Clin. Invest. 83 1989 1015 1031
2. D.B. Carter, E. Dunn, D.D. McKinley, N.C. Stratman, T.P. Boyle, S.L. Kuiper, J.A. Oostveen, R.J. Weaver, J.A. Boller, and M.E. Gurney Human apolipoprotein E4 accelerates β-amyloid deposition in APPsw transgenic mouse brain Ann. Neurol. 50 2001 468 475
3. H.S. Cho, B.T. Hyman, S.M. Greenberg, and G.W. Rebeck Quantitation of apoE domains in Alzheimer disease brain suggests a role for apoE in Aβ aggregation J. Neuropathol. Exp. Neurol. 60 2001 342 349
4. E.H. Corder, A.M. Saunders, N.J. Risch, W.J. Strittmatter, D.E. Schmechel, P.C. Gaskell Jr., J.B. Rimmler, P.A. Locke, P.M. Conneally, K.E. Schmader, G.W. Small, A.D. Roses, J.L. Haines, and M.A. Pericak-Vance Protective effect of apolipoprotein E type 2 allele for late onset Alzheimer disease Nat. Genet. 7 1994 180 184
5. E.H. Corder, A.M. Saunders, W.J. Strittmatter, D.E. Schmechel, P.C. Gaskell, G.W. Small, A.D. Roses, J.L. Haines, and M.A. Pericak-Vance Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families Science 261 1993 921 923
6. A.M. Fagan, G. Bu, Y. Sun, A. Daugherty, and D.M. Holtzman Apolipoprotein E-containing high density lipoprotein promotes neurite outgrowth and is a ligand for the low density lipoprotein receptor-related protein J. Biol. Chem. 271 1996 30121 30125
7. C.A. Fisher, and R.O. Ryan Lipid binding-induced conformational changes in the N-terminal domain of human apolipoprotein E J. Lipid Res. 40 1999 93 99
8. M. Gearing, H. Mori, and S.S. Mirra Aβ-peptide length and apolipoprotein E genotype in Alzheimer's disease Ann. Neurol. 39 1996 395 399
9. A.A. Golabek, E. Kida, M. Walus, C. Perez, T. Wisniewski, and C. Soto Sodium dodecyl sulfate-resistant complexes of Alzheimer's amyloid β-peptide with the N-terminal, receptor binding domain of apolipoprotein E Biophys. J. 79 2000 1008 1015
10. J.D. Harper, and P.T. Lansbury Jr. Models of amyloid seeding in Alzheimer's disease and scrapie: mechanistic truths and physiological consequences of the time-dependent solubility of amyloid proteins Annu. Rev. Biochem. 66 1997 385 407
11. U. Igbavboa, J. Hamilton, H.Y. Kim, G.Y. Sun, and W.G. Wood A new role for apolipoprotein E: modulating transport of polyunsaturated phospholipid molecular species in synaptic plasma membranes J. Neurochem. 80 2002 255 261
12. T.L. Innerarity, and R.W. Mahley Enhanced binding by cultured human fibroblasts of apo-E-containing lipoproteins as compared with low density lipoproteins Biochemistry 17 1978 1440 1447
13. T.L. Innerarity, R.E. Pitas, and R.W. Mahley Lipoprotein-receptor interactions Methods Enzymol. 129 1986 542 556
14. R.C. Kowal, J. Herz, K.H. Weisgraber, R.W. Mahley, M.S. Brown, and J.L. Goldstein Opposing effects of apolipoprotiens E and C on lipoprotein binding to low density lipoprotein receptor-related protein J. Biol. Chem. 265 1990 10771 10779
15. M.J. LaDu, M.T. Falduto, A.M. Manelli, C.A. Reardon, G.S. Getz, and D.E. Frail Isoform-specific binding of apolipoprotein E to β-amyloid J. Biol. Chem. 269 1994 23403 23406
16. M.J. LaDu, S.M. Gilligan, J.R. Lukens, V.G. Caban, C.A. Reardon, L.J. Van Eldik, and D.M. Holtzman Nascent astrocyte particles differ from lipoproteins in CSF J. Neurochem. 70 1998 2070 2081
17. M.J. LaDu, J.R. Lukens, C.A. Reardon, and G.S. Getz Association of human, rat, and rabbit apolipoprotein E with beta-amyloid J. Neurosci. Res. 49 1997 9 18
18. S. Lund-Katz, M. Zaiou, S. Wehrli, P. Dhanasekaran, F. Baldwin, K.H. Weisgraber, and M.C. Phillips Effects of lipid interaction on the lysine microenvironments in apolipoprotein E J. Biol. Chem. 275 2000 34459 34464
19. J. Ma, A. Yee, H.B. Brewer Jr., S. Das, and H. Potter Amyloid-associated proteins alpha 1-antichymotrypsin and apolipoprotein E promote assembly of Alzheimer beta-protein into filaments Nature 372 1994 92 94
20. J.A. Morrow, K.S. Arnold, and K.H. Weisgraber Functional characterization of apolipoprotein E isoforms over expressed in Escherichia coli Protein Expr. Purif. 16 1999 224 230
21. M. Narita, D.M. Holtzman, A.M. Fagan, M.J. LaDu, L. Yu, X. Han, R.W. Gross, G. Bu, and A.L. Schwartz Cellular catabolism of lipid poor apolipoprotein E via cell surface LDL receptor-related protein J. Biochem. (Tokyo) 132 2002 743 749
22. C. Nilsberth, A. Westlind-Danielsson, C.B. Eckman, M.M. Condron, K. Axelman, C. Forsell, C. Stenh, J. Luthman, D.B. Teplow, S.G. Younkin, J. Naslund, and L. Lannfelt The 'Arctic' APP mutation (E693G) causes Alzheimer's disease by enhanced Aβ protofibril formation Nat. Neurosci. 4 2001 887 893
23. J. Poirier Apolipoprotein E in animal models of CNS injury and Alzheimer's disease Trends Neurosci. 17 1994 525 530
24. V. Raussens, J. Drury, T.M. Forte, N. Choy, E. Goormaghtigh, J. Ruysschaert, and V. Narayanaswami Orientation and mode of lipid-binding interaction of human apolipoprotein E C-terminal domain Biochem. J. 387 2005 747 754
25. V. Raussens, C.M. Slupsky, B.D. Sykes, and R.O. Ryan Lipid-bound structure of an apolipoprotein E-derived peptide J. Biol. Chem. 278 2003 25998 26006
26. G.W. Rebeck, J.S. Reiter, D.K. Strickland, and B.T. Hyman Apolipoprotein E in sporadic Alzheimer's disease: allelic variation and receptor interactions Neuron 11 1993 575 580
27. H. Saito, P. Dhanasekaran, F. Baldwin, K.H. Weisgraber, M.C. Phillips, and S. Lund-Katz Effects of polymorphism on the lipid interaction of human apolipoprotein E J. Biol. Chem. 278 2003 40723 40729
28. D.A. Sanan, K.H. Weisgraber, S.J. Russell, R.W. Mahley, D. Huang, A. Saunders, D. Schmechel, T. Wisniewski, B. Frangione, A.D. Roses, and W.J. Strittmatter Apolipoprotein E associates with beta amyloid peptide of Alzheimer's disease to form novel monofibrils. Isoform apoE4 associates more efficiently than apoE3 J. Clin. Invest. 94 1994 860 869
29. A.M. Saunders, W.J. Strittmatter, D. Schmechel, P.H. St George-Hyslop, M.A. Pericak-Vance, S.H. Joo, G.L. Rosi, J.F. Gusella, D.R. Crapper-MacLachlan, M.J. Alberts, C. Hulette, B. Crain, D. Goldgaber, and A.D. Roses Association of apolipoprotein E allele epsilon 4 with late-onset familial and sporadic Alzheimer's disease Neurology 43 1993 1467 1472
30. M.L. Segall, P. Dhanasekaran, F. Baldwin, G.M. Anantharamaiah, K.H. Weisgraber, M.C. Phillips, and S. Lund-Katz Influence of apoE domain structure and polymorphism on the kinetics of phospholipids vesicle solubilization J. Lipid Res. 43 2002 1688 1700
31. D.J. Selkoe The molecular pathology of Alzheimer's disease Neuron 6 1991 487 498
32. 1-40 is toxic to inward channels of dissociated hippocampal and cortical neurons of rats Neurobiol. Dis. 14 2003 567 578
33. 1-40: a kinetic model J. Protein Chem. 22 2003 31 40
34. S.T. Thuahnai, S. Lund-Katz, G.M. Anantharamaiah, D.L. Williams, and M.C. Phillips A quantitative analysis of apolipoprotein binding to SR-BI: multiple binding sites for lipid-free and lipid-associated apolipoproteins J. Lipid Res. 44 2003 1132 1142
35. T. Tokuda, M. Calero, E. Matsubara, R. Vidal, A. Kumar, B. Permanne, B. Zlokovic, J.D. Smith, M.J. Ladu, A. Rostagno, B. Franione, and J. Ghiso Lipidation of apolipoprotein E influences its isoform-specific interaction with Alzheimer's amyloid beta peptides Biochem. J. 348 2000 359 365
36. P.M. Weers, V. Narayanaswami, N. Choy, R. Luty, L. Hicks, C.M. Kay, and R.O. Ryan Lipid binding ability of human apolipoprotein E N-terminal domain isoforms: correlation with protein stability? Biophys. Chem. 100 2003 481 492
37. K.H. Weisgraber Apolipoprotein E: structure-function relationships Adv. Protein Chem. 45 1994 249 302
38. T. Wisniewski, E.M. Castano, A. Golabek, T. Vogel, and B. Frangione Acceleration of Alzheimer's fibril formation by apolipoprotein E in vitro Am. J. Pathol. 145 1994 1030 1035
39. T. Wisniewski, and B. Frangione Apolipoprotein E: a pathological chaperone protein in patients with cerebral and systemic amyloid Neurosci. Lett. 135 1992 235 238